Vault-13

VALEANT PHARMACEUTICALS INTL

COM · CUSIP 91911K102

1 institutional holders +0 vs Q3 2023
644,000644.0k shares reported held*
$5.2mreported value*
0 new 0 added 1 reduced 0 sold out net sold ≈ $1.7m (-206.0k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.02.

Trends to Q4 2023

Institutional holders

Managers reporting a position, each quarter

001Q3 22: 1Q4 22: 1Q1 23: 1Q2 23: 1Q3 23: 1Q4 23: 11Q3 22Q4 22Q1 23Q2 23Q3 23Q4 23
Numbers
QuarterHolders
Q3 20221
Q4 20221
Q1 20231
Q2 20231
Q3 20231
Q4 20231

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
101Q4 22: 0 bought or addedQ4 22: 0 cut or sold outQ4 22Q1 23: 0 bought or addedQ1 23: 1 cut or sold outQ1 23Q2 23: 0 bought or addedQ2 23: 0 cut or sold outQ2 23Q3 23: 0 bought or addedQ3 23: 1 cut or sold outQ3 23Q4 23: 0 bought or addedQ4 23: 1 cut or sold outQ4 23
Numbers
QuarterBought or addedCut or sold out
Q4 202200
Q1 202301
Q2 202300
Q3 202301
Q4 202301

Biggest buyers

None

Biggest sellers

Bruce & Co., Inc. Reduced -206,000-206.0k

Holders, Q4 2023

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Bruce & Co., Inc. 1.80% of their portfolio CHICAGO, IL 644,000644.0k $5.2m $5.2m 1.80% Reduced -206.0k -206,000